UBS Group AG

Q4 2022 13F-HR Holdings

Location
Zurich, V8
Holdings as of
12/31/2022
Date filed
2/8/2023
Form type
13F-HR
Num holdings
10,681
Total value ($000)
$267,823,800
Net value change ($000)
+39,730,939 (17.4%)
New positions
889
Sold out positions
1013
Turnover %
0.7%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 11/10/2022 Next filing: 5/12/2023 SEC filing

Snapshot: Change Analysis

Compared to Q3 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
MSFT 1,018,674 17.8%
JPM 604,225 35.4%
PG 506,609 41.7%
CVX 498,439 53.5%
JNJ 483,095 28.3%
UBS GROUP AG 482,999 27.2%
XOM 462,920 63.0%
MRK 462,269 48.9%
AVGO 426,425 50.8%
ABBV 422,292 31.9%
Top Reduces (Value $000, Stocks/ETFs)
AMZN -629,407 -23.4%
CRM -404,331 -48.0%
META -340,197 -39.5%
CTXS -222,878 -100.0%
IYR -206,629 -64.9%
Biohaven Pharmaceutical Holding Co Ltd. -125,995 -100.0%
FXE -106,558 -93.8%
XBI -103,841 -49.1%
MDT -100,926 -15.6%
TWTR -95,002 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 59,514,422 (22.2% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type